Recent Articles from StockStory

Digital infrastructure provider Applied Digital (NASDAQ:APLD) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 98% year on year to $126.6 million. Its non-GAAP loss of $0 per share was significantly above analysts’ consensus estimates.

Investment banking firm Jefferies Financial Group (NYSE:JEF) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 5.7% year on year to $2.07 billion. Its GAAP profit of $0.85 per share was 10% below analysts’ consensus estimates.

Electronics distributor Richardson Electronics (NASDAQ:RELL) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 5.7% year on year to $52.29 million. Its GAAP loss of $0.01 per share was in line with analysts’ consensus estimates.

Metal coating and infrastructure solutions provider AZZ (NYSE:AZZ) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5.5% year on year to $425.7 million. The company’s full-year revenue guidance of $1.66 billion at the midpoint came in 1.4% above analysts’ estimates. Its non-GAAP profit of $1.52 per share was 2.5% above analysts’ consensus estimates.

Beer, wine, and spirits company Constellation Brands (NYSE:STZ) reported Q4 CY2025 results topping the market’s revenue expectations, but sales fell by 9.8% year on year to $2.22 billion. Its non-GAAP profit of $3.06 per share was 16.2% above analysts’ consensus estimates.

Sushi restaurant chain Kura Sushi (NASDAQ:KRUS) met Wall Streets revenue expectations in Q4 CY2025, with sales up 14% year on year to $73.46 million. The company’s full-year revenue guidance of $332 million at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP loss of $0.23 per share was 45.6% below analysts’ consensus estimates.

Shares of data security company Varonis Systems (NASDAQ:VRNS) jumped 6.1% in the afternoon session after Cantor Fitzgerald maintained an Overweight rating on the data security company despite lowering its price target. 

Shares of electricity generation and hydrogen production company Bloom Energy (NYSE:BE) jumped 7.3% in the afternoon session after a prominent analyst increased the company's price target to $58, and the company announced a new $600 million credit facility. 

Shares of architectural products company Apogee (NASDAQ:APOG) fell 12.7% in the afternoon session after it reported disappointing fourth-quarter 2025 results and issued a weak financial outlook for the upcoming year. For the quarter, while adjusted earnings of $1.02 per share narrowly beat analyst expectations, revenue of $348.6 million fell short of estimates. The company's profitability was squeezed, with its operating margin falling to 7.1% from 10.3% in the same quarter last year, reflecting what the company described as a more competitive environment and higher input costs. Compounding the weak results, management's forecast for the full year also fell short of Wall Street's projections. The company's full-year adjusted earnings per share guidance of $3.45 at the midpoint missed analyst estimates by 6%, and its revenue outlook of $1.39 billion was also below expectations. Overall, the combination of a revenue miss and a disappointing forward-looking forecast soured investor sentiment.

Shares of computer processor maker Intel (NASDAQ:INTC) jumped 6.6% in the afternoon session after the company showcased its new, advanced processors for AI-powered PCs and gaming devices at the CES 2026 trade show. 

Shares of human capital management provider Alight (NYSE:ALIT) fell 7.1% in the afternoon session after the company announced its Chief Financial Officer, Jeremy Heaton, would be leaving the company. 

Shares of affordable single-family home construction company LGI Homes (NASDAQ:LGIH) jumped in the afternoon session after the company reported a significant increase in home closings for December and received a price target increase from an analyst. LGI Homes announced it had closed 569 homes in December, a 43% jump from the previous month. This brought the company's fourth-quarter total to 1,362 homes closed and the full-year number to 4,788. Following the strong operational update, Citizens analyst James McCanless raised the firm's price target on LGI Homes to $95 from $85. The analyst also kept an Outperform rating on the shares, pointing to the monthly closing reports as a key catalyst for the company.

Shares of cybersecurity platform provider CrowdStrike (NASDAQ:CRWD) jumped 5.3% in the afternoon session after Cantor Fitzgerald reiterated its Overweight rating on the stock, citing the company's accelerating business momentum and improved financial outlook. 

Shares of hospital management company Universal Health Services (NYSE:UHS) fell 5.4% in the afternoon session after Wells Fargo downgraded the hospital operator to Equal Weight from Overweight and cut its price target. 

Shares of glass and windows manufacturer Tecnoglass (NYSE:TGLS) fell 5.5% in the morning session after its competitor, Apogee Enterprises (APOG), reported disappointing third-quarter results and cut its full-year financial outlook. 

Shares of government services provider Maximus (NYSE:MMS) jumped 3.2% in the morning session after its Board of Directors approved a 10% increase in the quarterly cash dividend to $0.33 per share. 

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.3% in the morning session after the company announced a partnership to develop a new oral obesity drug and was reported to be in advanced talks to acquire Ventyx Biosciences for over $1 billion. 

Shares of real estate technology company Compass (NYSE:COMP) jumped 12.4% in the morning session after its planned merger with Anywhere Real Estate cleared a significant regulatory hurdle, overshadowing news of a large debt offering. 

Shares of aerospace and defense company Rocket Lab (NASDAQ:RKLB) fell 2% in the morning session after a filing with the Securities and Exchange Commission revealed a significant stock sale by the company's Chief Commercial Officer, Frank Klein. 

Shares of grocery retailer Albertsons (NYSE:ACI) fell 7.6% in the morning session after the company reported its third-quarter 2025 results, which featured a mixed financial outlook for the full year. 

Shares of agricultural and farm machinery company Titan (NSYE:TWI) fell 2% in the morning session after reports indicated negative insider sentiment, driven by significant open-market selling from key executives.

Shares of footwear conglomerate Wolverine Worldwide (NYSE:WWW) fell 7.2% in the morning session after Piper Sandler downgraded the stock from Overweight to Neutral and lowered its price target. 

Shares of footwear company Crocs (NASDAQ:CROX) fell 4.8% in the morning session after Baird downgraded the stock from 'Outperform' to 'Neutral', citing valuation concerns. 

Shares of carbonate fuel cell technology developer FuelCell Energy (NASDAQ:FCEL) fell 8.1% in the morning session after the company announced it had terminated its Executive Vice President, General Counsel, and Corporate Secretary, Joshua Dolger, without cause. The termination was effective January 6, 2026. FuelCell's board moved quickly to name a replacement, appointing Amanda J. Schreiber to the same roles, starting on January 12, 2026. Sudden changes in key leadership, especially an executive termination described as being "without cause," can create uncertainty for investors regarding a company's internal stability and direction. The market's reaction suggested concern over the unexpected management shuffle.

Shares of solar panel manufacturer First Solar (NASDAQ:FSLR) fell 10% in the morning session after Jefferies downgraded the stock to 'Hold' from 'Buy' and lowered its price target to $260 from $269. 

Shares of tanking company Scorpio Tankers (NYSE:STNG) jumped 5% in the morning session after analyst sentiment turned bullish as the company was seen as well-positioned to gain from an expected rise in product tanker rates. 

Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) jumped 3.7% in the morning session after the company announced positive top-line results from a late-stage study of its lymphoma drug, Monjuvi/Minjuvi (tafasitamab). The Phase III trial, called frontMIND, tested the drug as a first-line treatment for adults with a type of cancer known as diffuse large B-cell lymphoma (DLBCL). The study successfully met its main goal, showing a statistically meaningful improvement in how long patients lived without their disease getting worse. Based on these strong results, Incyte planned to submit a supplemental biologics license application to the FDA in the first half of 2026 to seek approval for this expanded use.

Shares of infrastructure equipment supplier SPX Technologies (NYSE:SPXC) fell 1.1% in the morning session after investor concerns persisted over a potential shift in data center cooling technology announced by Nvidia. 

Shares of fashion conglomerate PVH (NYSE:PVH) fell 5.5% in the morning session after Telsey Advisory downgraded the stock to Market Perform from Outperform and cut its price target. The firm lowered its price view on the shares to $82 from a previous $95. The downgrade was based on the assessment that PVH's business was in transition. This move happened as the broader value fashion segment faced intensifying competition, putting pressure on apparel retailers.

Shares of biotech company Regeneron (NASDAQ:REGN) jumped 2.9% in the morning session after Bank of America Securities upgraded its rating on the company's stock from 'Underperform' to 'Buy' and significantly raised its price target. The firm's analyst, Tim Anderson, lifted the price target to $860.00 from a previous $627.00. This move signaled growing confidence in Regeneron's market prospects. Adding to the positive sentiment, Citi also raised its price target on the shares to $900 from $700 while keeping its 'Buy' rating. Reflecting the bullish analyst actions, the stock reached a new 52-week high, underscoring the positive momentum.

Shares of electronic bond trading platform MarketAxess (NASDAQ:MKTX) fell 4% in the morning session after the company announced its trading volume statistics for December and the fourth quarter of 2025, which showed a decline in transaction fees. 

Shares of electricity storage and software provider Fluence (NASDAQ:FLNC) fell 7.1% in the morning session after a consensus among Wall Street analysts pointed to a significant potential downside, citing pricing pressures and a weak earnings outlook. 

Shares of coconut water company The Vita Coco Company (NASDAQ:COCO) jumped 5.2% in the morning session after an analyst at Wells Fargo raised the company's price target. The firm maintained its "Buy" rating on the stock but increased its price target to $63 from $50. This new target represented a potential upside of about 19% from the stock's price at the time of the report. A significant price target increase from a financial analyst often reflects a more positive outlook on a company's potential for growth and profitability. This can lead to increased investor confidence and drive buying activity, which appeared to be the case for Vita Coco.

Shares of clothing company Kontoor Brands (NYSE:KTB) fell 4.2% in the morning session after Barclays lowered its price target on the company's shares to $74 from $94. The analyst firm kept an "Overweight" rating on the stock. The price target change was part of a broader adjustment to its 2026 outlook for the specialty retail sector. While Barclays noted some positive economic signs, the firm also pointed to persistent "demand uncertainty" as a key reason for the revision. This note of caution from the analyst likely concerned investors, leading to the stock's decline.

Shares of aviation and defense services provider AAR CORP (NYSE:AIR) jumped 6.2% in the morning session after the company reported strong fourth-quarter 2025 results that surpassed analyst expectations and provided an optimistic forecast. 

Semiconductor maker Penguin Solutions (NASDAQ:PENG) reported Q4 CY2025 results topping the market’s revenue expectations, but sales were flat year on year at $343.1 million. Its non-GAAP profit of $0.49 per share was 10.6% above analysts’ consensus estimates.

Intelligent lighting and space solutions provider Acuity Brands (NYSE:AYI) will be announcing earnings results tomorrow before market open. Here’s what investors should know.

Grocery retailer Albertsons (NYSE:ACI) met Wall Streets revenue expectations in Q3 CY2025, with sales up 2% year on year to $18.92 billion. Its non-GAAP profit of $0.44 per share was 10.6% above analysts’ consensus estimates.

Workplace uniform provider UniFirst (NYSE:UNF) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 2.7% year on year to $621.3 million. The company expects the full year’s revenue to be around $2.49 billion, close to analysts’ estimates. Its GAAP profit of $1.89 per share was 5.1% below analysts’ consensus estimates.

Check out the companies making headlines yesterday:

Industrial supplies company MSC Industrial Direct (NYSE:MSM) met Wall Streets revenue expectations in Q4 CY2025, with sales up 4% year on year to $965.7 million. Its non-GAAP profit of $0.99 per share was 4.8% above analysts’ consensus estimates.

Architectural products company Apogee (NASDAQ:APOG) missed Wall Street’s revenue expectations in Q4 CY2025 as sales rose 2.1% year on year to $348.6 million. The company’s full-year revenue guidance of $1.39 billion at the midpoint came in 1.4% below analysts’ estimates. Its non-GAAP profit of $1.02 per share was 1% above analysts’ consensus estimates.

Egg company Cal-Maine Foods (NASDAQ:CALM) fell short of the markets revenue expectations in Q4 CY2025, with sales falling 19.4% year on year to $769.5 million. Its GAAP profit of $2.13 per share was 9.9% above analysts’ consensus estimates.

Software is eating the world, and virtually no business is left untouched by it. In the past, the undeniable tailwinds fueling SaaS companies led to lofty valuation multiples that made it easier to raise capital. But this was a double-edged sword as the high prices exposed them to big drawdowns, and unfortunately, the industry has tumbled by 4.6% over the last six months. This performance is a noticeable divergence from the S&P 500’s 10.8% return.

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 19.9% gain over the past six months, beating the S&P 500 by 9.1 percentage points.

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.

Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?

Banks play a critical role in the financial system, providing everything from commercial loans to wealth management and payment processing services. But worries about an economic slowdown and potential credit deterioration have kept sentiment in check, and over the past six months, the banking industry’s 6.4% return has trailed the S&P 500 by 4.4 percentage points.

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices, leaving little room for error if they stumble even slightly.

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.

Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

Restaurants are go-to meeting hubs for friends, family, and colleagues. Still, their demand can ebb and flow with the broader economy because consumers can always cook meals at home when times are tough, and the market seems to be baking in a downturn for the industry - over the past six months, it has pulled back by 11.1%. This drop is a noticeable divergence from the S&P 500’s 10.8% return.

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.

The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends of the investing world.

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.

A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared.

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.